Literature DB >> 12200048

The role of the proteasome activator PA28 in MHC class I antigen processing.

Alice Sijts1, Yuancheng Sun, Katarina Janek, Sylvie Kral, Annettte Paschen, Dirk Schadendorf, Peter-M Kloetzel.   

Abstract

The proteasome system is the major source for the generation of viral antigens and tumor antigens presented by major histocompatibility complex class I (MHC class I) molecules. A specific feature of the proteasomal antigen processing machinery is that five of its components are inducible by IFN-gamma. Two of these are the alpha and beta subunits of the proteasome activator PA28. Our results show that PA28 selectively up-regulates the presentation of viral MHC class I epitopes and that down regulation PA28 in tumor cells results in impaired presentation of a human TRP2 tumor antigen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200048     DOI: 10.1016/s0161-5890(02)00099-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  35 in total

1.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

2.  Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon.

Authors:  Suchira Bose; Fiona L L Stratford; Kerry I Broadfoot; Grant G F Mason; A Jennifer Rivett
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 3.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

4.  Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Authors:  Nicholas J Steers; Jeffrey R Currier; Gustavo H Kijak; Robert C di Targiani; Ashima Saxena; Mary A Marovich; Jerome H Kim; Nelson L Michael; Carl R Alving; Mangala Rao
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

Review 5.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

7.  Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.

Authors:  Yoshinori Ito; Eisei Kondo; Ayako Demachi-Okamura; Yoshiki Akatsuka; Kunio Tsujimura; Mitsune Tanimoto; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Dynamic changes in the numbers of different subsets of peripheral blood NK cells in patients with systemic lupus erythematosus following classic therapy.

Authors:  Hongshuang Ma; Ling Zhao; Zhenyu Jiang; Yanfang Jiang; Li Feng; Zhuang Ye
Journal:  Clin Rheumatol       Date:  2014-07-15       Impact factor: 2.980

9.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

10.  Chronic ethanol feeding affects proteasome-interacting proteins.

Authors:  Marie-Pierre Bousquet-Dubouch; Sheila Nguen; David Bouyssié; Odile Burlet-Schiltz; Samuel W French; Bernard Monsarrat; Fawzia Bardag-Gorce
Journal:  Proteomics       Date:  2009-07       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.